Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | TSHR | P16473 | 8/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | PPARG | P37231 | 6/20 | 0.39 |
| ▸ | PPARD | Q03181 | 6/20 | 0.39 |
| ▸ | PPARA | Q07869 | 6/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL58343 | 0.95 | LMNA (0.67) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL14809980 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL3504682 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL515855 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL3505211 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL14809715 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL14809726 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL14809112 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL14809593 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 | |
| SCHEMBL3504230 | 0.93 | LMNA (0.70) | LMNATSHRSLC22A6NFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105685021-A | Insecticide mother liquor and application thereof | 中山榄菊日化实业有限公司 | 2016-06-22 | — | — | CN | claimed |
| US-7399880-B2 | Process for removing farnesol from mixtures with alpha-bisabolol | SYMRISE GMBH & CO. KG (DE) | 2008-07-15 | — | — | US | claimed |
| US-20070100160-A1 | PROCESS FOR REMOVING FARNESOL FROM MIXTURES WITH ALPHA-BISABOLOL | SYMRISE AG (DE) | 2007-05-03 | — | — | US | claimed |
| US-4209438-A | CROSSLINKED POLYESTER IN DIFUNCTIONAL CARBOXYLIC ESTER SOLVENT | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1980-06-24 | — | — | US | claimed |
| US-20260084095-A1 | Hydrophobic Alkyl-Ester Physical Solvents for CO2 Removal from H2 Produced from Synthesis Gas | US ENERGY (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-3471737-B1 | CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME LLC (US) | 2025-06-04 | — | — | EP | disclosed |
| US-20230043712-A1 | Hydrophobic Alkyl-Ester Physical Solvents for CO2 Removal from H2 Produced from Synthesis Gas | U.S. DEPARTMENT OF ENERGY | 2023-02-09 | — | — | US | disclosed |
| US-10899788-B2 | Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases | MERCK SHARP & DOHME CORP. (US) | 2021-01-26 | — | — | US | disclosed |
| US-20190233463-A1 | CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2019-08-01 | — | — | US | disclosed |
| EP-3471737-A1 | CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | Merck Sharp & Dohme Corp. (US) | 2019-04-24 | — | — | EP | disclosed |
| US-10023760-B2 | Semicarbazide composition, method for producing semicarbazide composition, aqueous polymer composition and composite | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-07-17 | — | — | US | disclosed |
| US-4483961-A | Polymeric cyclopentadiene derivatives, method for preparing and use thereof | ASHLAND OIL, INC. (US) | 1984-11-20 | — | — | US | disclosed |
| US-4482653-A | Cyclopentadiene derivatives, method for preparing, and use thereof | ASHLAND OIL, INC. (US) | 1984-11-13 | — | — | US | disclosed |
| US-4464521-A | EPOXIDIZED FULVENES AS BINDER FOR AGGREGATE; FOUNDRY BINDERS | ASHLAND OIL, INC. (US) | 1984-08-07 | — | — | US | disclosed |
| US-4412088-A | CURABLE BINDER COMPOSITIONS | ASHLAND OIL, INC. (US) | 1983-10-25 | — | — | US | disclosed |
| US-4390675-A | EPOXYFULVENE, ACID CATALYST | ASHLAND OIL, INC. (US) | 1983-06-28 | — | — | US | disclosed |
| US-4220578-A | Method, resin and catalyst for increasing the tensile strength and core hardness of a sand mold or core | CL INDUSTRIES INC. (US) | 1980-09-02 | — | — | US | disclosed |
| US-4215012-A | SULFUR-FREE; DIALKYL ESTER COMPOUND AND A LEWIS ACID, POLYMERIZATION CATALYST | C L INDUSTRIES, INC. (US) | 1980-07-29 | — | — | US | disclosed |
| US-4209438-A | CROSSLINKED POLYESTER IN DIFUNCTIONAL CARBOXYLIC ESTER SOLVENT | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1980-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10899788-B2 | Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases | PNP, TYMP, NUDT1 | LMNA 2461/4885TSHR 3542/4885SLC22A6 367/4885 |
| US-20070100160-A1 | PROCESS FOR REMOVING FARNESOL FROM MIXTURES WITH ALPHA-BISABOLOL | CES1, FNTB, CBR1 | LMNA 791/4885TSHR 676/4885SLC22A6 3314/4885 |
| US-10023760-B2 | Semicarbazide composition, method for producing semicarbazide composition, aqueous polymer composition and composite | C9, C5, BRD2 | LMNA 1640/4885TSHR 3717/4885SLC22A6 779/4885 |
| US-20260084095-A1 | Hydrophobic Alkyl-Ester Physical Solvents for CO2 Removal from H2 Produced from Synthesis Gas | SCD, ELOVL3, ACAD10 | LMNA 1631/4885TSHR 3789/4885SLC22A6 1256/4885 |
| US-20190233463-A1 | CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | PNP, TYMP, NUDT1 | LMNA 2461/4885TSHR 3542/4885SLC22A6 367/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | LMNA 399/4885TSHR 1822/4885SLC22A6 3062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.